London: The Oxford-AstraZeneca vaccine, whose Indian version is Covishield, is going through a rough phase. After 8 European nations temporarily suspended the vaccine due to possible blood clots, countries like Thailand are delaying its rollout.
The European Union’s drug regulator has now recommended adding severe allergy (anaphylaxis and hypersensitivity) as possible side effects.
This is based on 41 reports of possible anaphylaxis from around 5 million vaccinations in the UK.
It is important to note that the European Medicines Agency (EMA) is investigating the development of blood clots post vaccination, that prompted Italy, Norway and Denmark to suspend the jab. EMA, however, added that the vaccine is safe for use.
Anaphylaxis is known to be a common reaction to vaccines. The AstraZeneca shot carries a label that advises patients be kept under close observation for 15 minutes.
Also Read: Eight EU Nations Stop Using AstraZeneca Vaccine
Bhubaneswar: An attempt for an amicable settlement of the dispute, involving Ollywood director Bobby Islam…
Bhubaneswar: Dense fog occurred at one or two places in Sundargarh and shallow to moderate…
Mumbai: The Mumbai Police crime branch revealed that an accused in the Baba Siddiqui murder…
Bhubaneswar: Kashika Misra has created history by becoming the first Odia girl to win any…
Moscow: President Vladimir Putin has warned the countries that allow Ukraine to use their weapons…
Bhubaneswar: After a five-month-long investigation, Jharsuguda police in Odisha busted an inter-state cybercrime racket and…
Bhubaneswar: Vedanta Aluminium has expanded its ‘Swarna Prashan’ initiative, an Ayurveda-based immunisation drive, to over…
Ottawa: The government in Canada, led by Justin Trudeau, on Friday denied linking Prime Minister…